In the SURMOUNT-1 trial, which evaluated tirzepatide for chronic weight management in adults without diabetes, approximately 67% of participants were women
For example, if you are already taking a GLP-1 covered by Part D for type 2 diabetes, cardiovascular risk reduction, or another indication, you will continue receiving that medication through your Part D plan
This study aims to uncover which medication has greater efficacy and safety in CKD and HF patients with type 2 diabetes patients
Call (770) 800-3353 to set up your first consultation.
Thats because just as much as saving lives and fighting illness happens every day at our Wellstar healthcare facilities, staying well starts with you
Image Credit: Nastyaofly / Shutterstock In a recent study published in the journal Nutrients , researchers at Texas Tech University in the United States investigated the presence of semaglutide in breast milk